A study to see the surgical outcomes and how safe and effective is the new laser machine MEL 90
- Conditions
- Health Condition 1: null- Patients with Myopia, Hypermetropia and Astigmatism undergoing treatment on the MEL 90 excimer laser platform
- Registration Number
- CTRI/2014/09/005061
- Lead Sponsor
- ETHRADHAMA SUPERSPECIALITY EYE HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
•Any gender, 21 to 40 years of age
•Stable corneal conditions within the last 12 months
•Stable refraction since past 12 months ( <0.5D change within past 12 months)
•Healthy ocular surface with stable tear film
•Discontinuation of Soft contact lenses 1 week, and rigid contact lenses 3 weeks prior to surgery
•For myopia correction, myopia upto -10 Diopters
•For hyperopia correction, hyperopia upto + 3 Diopters
•For astigmatic correction, astigmatism upto 3 Diopters
•Thin corneas (Corneal pachymetry <480u)
•Steep corneas Kmax >48 D
•Keratoconus suspects or frank keratoconus
•Moderate to severe dry eye (Shirmers1 <10 mm)
•Socket / globe /lid anomalies â?? very deep set eyes, nanophthalmos
•Severe meibomian gland disease, lid abnormalities
•Severe atopy
•Contact lens overuse
•Pregnant and nursing mother
•Autoimmune disorders
•Pts on systemic medications eg Iso retinoic acid, hormonal preperations, OCPs, antidepressants.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy, safety and refractive outcomes of MEL 90 Excimer laser platform.Timepoint: 6 MONTHS
- Secondary Outcome Measures
Name Time Method OT APPLICABLETimepoint: NOT APPLICABLE